News | February 10, 2011

New Possibilities for UK Patients With Difficult-to-Treat Cancers

February 10, 2011 – For the first time in the UK, cancer patients are starting to receive treatment with Novalis Tx radiosurgery. This device, by Brainlab and Varian Medical Systems, gives the chance of a cure to those with inoperable tumors and offers the possibility to perform precise, painless treatment in a single patient visit.

The system makes it possible for doctors to treat patients with tumors virtually anywhere in the body in just a single session. Combining a 'sat nav' like targeting system and powerful treatment beams, it can destroy cancerous cells and helps to protect surrounding healthy tissue. Treatment is also made more patient-friendly by delivering frameless radiosurgery for brain tumors, an alternative to techniques that require immobilization with an invasive head ring that is affixed to the skull.

In its first year of operation at the brand new Clatterbridge Cancer Centre in Liverpool, it is expected to treat more than 800 cancer patients. It is estimated that 150 of these patients will be priority brain tumor patients where precise, non-invasive treatment is particularly effective.

"Unlike some other highly specialized radiation treatment machines, the Novalis Tx can treat many different types of cancer in all over the body allowing us to treat more cancer patients with a single device,” said Brian Haylock, consultant oncologist and clinical director for radiotherapy at Clatterbridge Centre for Oncology. “This coupled with the speed with which we can treat patients - in some cases in as little as 15 minutes in just one session - means the equipment will be available for the benefit of more patients here in the UK."

Later this year, Novalis Tx machines will become operational at two other specialist NHS cancer centers in Edinburgh and Manchester.

For more information: www.brainlab.com, www.varian.com

Related Content

Insightec Announces Expanded Reach of MR-Guided Focused Ultrasound
News | Focused Ultrasound Therapy | August 22, 2017
Insightec announced recently that worldwide adoption of magnetic resonance (MR)-guided focused ultrasound continues to...
UCLA Study Offers Roadmap to Personalized Therapies for Sarcoma
News | Oncology Diagnostics | August 22, 2017
A new UCLA study is the first to identify patient and tumor characteristics that predict the successful creation of...
Sponsored Content | Videos | Information Technology | August 22, 2017
Melissa Martin, MS, president of the American Association of Physicists in Medicine (AAPM), discusses her vision of t
Sponsored Content | Videos | Proton Therapy | August 21, 2017
Mark Pankuch, Ph.D., director of medical physics at the Northwestern Medicine Chicago Proton Center, discusses the cl
Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | August 21, 2017
Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Overlay Init